Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effects of Motivating People With Schizophrenia to Exercise
This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), August 2008
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00559572
  Purpose

This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their participation in a walking program.


Condition Intervention
Schizophrenia
Behavioral: Motivational group sessions
Other: Time and attention control group sessions

MedlinePlus related topics: Exercise and Physical Fitness Schizophrenia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Motivating Persons With Schizophrenia to Exercise

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • Exercise group attendance [ Time Frame: Measured at Week 16 ] [ Designated as safety issue: No ]
  • Exercise group persistence [ Time Frame: Measured at Weeks 4,8, 12 & 16 ] [ Designated as safety issue: No ]
  • Exercise group compliance [ Time Frame: Measured at Weeks 4,8,12 & 16 ] [ Designated as safety issue: No ]
  • Exercise attitude [ Time Frame: Measured at Weeks 4,8,12 and 16 ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: November 2007
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Exercise information group
Behavioral: Motivational group sessions
Motivational group sessions include 4 weeks of weekly 1-hour exercise information sessions.
2: Active Comparator
General health information group
Other: Time and attention control group sessions
Time and attention control group sessions include 4 weeks of weekly 1-hour general health information sessions.

Detailed Description:

Schizophrenia is a chronic brain disorder that affects about 1% of Americans. People with schizophrenia experience extreme paranoia, often claiming that they hear voices not heard by others and that others are invading or controlling their minds with the intent to hurt them. More specific symptoms include hallucinations, delusional behaviors, disordered movements, and decreased ability to comprehend and apply information to everyday activities. The severity of these symptoms makes self-care and regular exercise difficult for people with schizophrenia. The fatality rate from diabetes, heart disease, and other obesity-related illnesses is significantly higher in people with schizophrenia. Exercise is known to reduce health problems associated with obesity, yet few studies have encouraged exercise as a treatment method for improving the health of those with schizophrenia. Furthermore, the long-term physical and mental effects of consistent exercise on people with schizophrenia are not well-known. This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their attendance, persistence, and compliance to a walking program.

Participants in this study will be randomly assigned to one of two groups. Both groups will continue their regular medications and treatments throughout the study. Upon entry, members of both groups will complete the same two forms concerning attitudes toward exercise. Group 1 participants will attend weekly 1-hour exercise information sessions for 4 weeks. Group 2 participants will attend weekly 1-hour general health information sessions for the same 4 weeks. Participants of both groups will then take part in identical 16-week walking programs. The walking program will consist of three 30- to 50-minute walks per week, including 10 minutes of warm up and 10 minutes of cool down stretching. All participants will gradually increase their walking time from 5 minutes to 30 minutes during the program. At the completion of the walking programs, participants of both groups will complete repeat forms about their attitudes toward exercise. There will be no follow-up visits for the participants.

  Eligibility

Ages Eligible for Study:   22 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Meets DSM-IV criteria for schizophrenia
  • Speaks English
  • Stable medication regimen
  • Able to receive medical clearance for moderate exercise

Exclusion Criteria:

  • Hospitalized within 1 year of study entry for angina, heart attack, or cardiac surgery
  • Diagnosed with congestive heart failure
  • Has a pacemaker
  • Heart rate less than 50 bpm or more than 100 bpm at rest
  • Uncontrolled hypertension
  • History of spinal or hip fracture
  • Unable to walk or move around without assistance
  • Any other medical condition, in the opinion of primary care provider, that would prevent safe participation in the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00559572

Contacts
Contact: Lora L. Beebe, Phd, PMHNP-BC 865-974-3978 lbeebe1@utk.edu

Locations
United States, Tennessee
Helen Ross McNabb Center Recruiting
Knoxville, Tennessee, United States, 37917
Sponsors and Collaborators
Investigators
Principal Investigator: Lora L. Beebe, PhD, PMHNP, BC University of Tennessee
  More Information

Responsible Party: University of Tennessee ( Lora L. Beebe, PhD, PMHNP, BC )
Study ID Numbers: R03 MH079047
Study First Received: November 14, 2007
Last Updated: August 19, 2008
ClinicalTrials.gov Identifier: NCT00559572  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Exercise
Group Counseling
Obesity

Study placed in the following topic categories:
Schizophrenia
Obesity
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 30, 2009